Comparison between of the attenuated BR-Oka and the wild type strain of Varicella Zoster Virus (VZV) on the DNA level.
Oka strain VR-795 (Varicella Zoster Virus, VZV) of American Type Culture Collection (ATCC) has been used for chickenpox vaccine production. In order to use this strain for vaccine production, the strain must be identified and its stability must be confirmed. The identification of the Oka strain has been confirmed using Restriction Fragment Length Polymorphism (RFLP) and DNA sequence analysis of glycoprotein-II (gp-II). The amino acid sequences of Oka deduced from the DNA sequence of gp-II have changed at three amino acids against Ellen and at one amino acid against Webster. To prove the stability of the Oka strain during the passage, RFLP and DNA sequence analyses were also used with 11, 15 and 23 times of virus passage. We found that the Oka strain was stable at passages of up to 23 times, based on the RFLP and DNA sequence analyses. The confirmed Oka strain was renamed as BR-Oka for the purposes of chickenpox vaccine production.
Lim
S M
SM
Boryung Central Research Institute, Boryung Pharm.Co.,Ltd., Kyungki-Do, Korea.
Song
S W
SW
Kim
S L
SL
Jang
Y J
YJ
Kim
K H
KH
Kim
H J
HJ
D000595:Amino Acid Sequence; D001483:Base Sequence; D019433:Chickenpox Vaccine; D004269:DNA, Bacterial / Q000737:chemistry*; D014645:Herpesvirus 3, Human / Q000145:classification* / Q000235:genetics; D008969:Molecular Sequence Data; D012150:Polymorphism, Restriction Fragment Length; D014613:Vaccines, Attenuated
D019433:Chickenpox Vaccine; D004269:DNA, Bacterial; D014613:Vaccines, Attenuated